Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). حسب Naoya Itoh (6029276)

Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). حسب Naoya Itoh (6029276)

Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... حسب Naoya Itoh (6029276)

Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... حسب Naoya Itoh (6029276)

Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... حسب Naoya Itoh (6029276)

Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... حسب Naoya Itoh (6029276)

Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... حسب Naoya Itoh (6029276)

General linear mixed model coefficients and significance for species-specific ungulate intensity of use as a function of cattle grazing period. حسب Kathryn Knodel (20036529)

Results of the General Linear Model (stepwise full model) used to test for each patient the association between haematochemical examinations performed at the baseline (dependent va... حسب Domenico Maurizio Toraldo (9071920)

الموضوعات:

IMP-1088 decreases infectivity of progeny VACV particles. حسب Lalita Priyamvada (421536)

Decrease in VACV infectivity linked to defect in viral entry. حسب Lalita Priyamvada (421536)

Fig 4 - حسب Michelle Gelippi (9580022)

Fig 3 - حسب Pedro A. R. Vanzele (17655589)

Post-mortem lesions of chickens with decreased egg production in Yancheng in 2023. حسب Yan Wang (15435)

Diagram of the mechanism by which PFAS causes a decrease in constipation. حسب Yifan Zhao (659636)